Bill
Bill > HF105
summary
Introduced
01/22/2025
01/22/2025
In Committee
01/22/2025
01/22/2025
Crossed Over
Passed
Dead
Introduced Session
91st General Assembly
Bill Summary
This bill relates to the medical cannabidiol program. The bill changes the definition of “medical cannabidiol” to include specific forms of oral, topical, and inhalable cannabis.
AI Summary
This bill modifies the legal definition of "medical cannabidiol" in Iowa's medical cannabis program to expand the allowable forms of cannabis that can be used for medical purposes. Specifically, the bill broadens the definition to explicitly include three main categories of medical cannabis delivery methods: oral forms (such as tablets, capsules, liquids, tinctures, and sublingual preparations), topical forms (including gels, ointments, creams, lotions, and transdermal patches), and inhaled forms (limited to nebulizable inhalable cannabis, vaporizable dried raw cannabis, and other vaporizable cannabis forms). By providing this detailed and comprehensive list of acceptable medical cannabis formats, the bill aims to give patients and healthcare providers more flexibility in how medical cannabidiol can be administered, potentially increasing accessibility and treatment options for individuals who may benefit from medical cannabis. The bill represents an update to the existing medical cannabidiol statute, reflecting an evolving understanding of cannabis as a medical treatment and potential therapeutic option.
Committee Categories
Health and Social Services
Sponsors (1)
Last Action
Committee report approving bill, renumbered as HF 950. (on 03/12/2025)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.legis.iowa.gov/legislation/BillBook?ga=91&ba=HF105 |
| BillText | https://www.legis.iowa.gov/docs/publications/LGI/91/attachments/HF105.html |
Loading...